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Abstract In Poland, nuclear medicine (NM) has been an
independent specialty since 1988. At the end of 2013, the
syllabus for postgraduate specialization in NM has been modi-
fied to be in close accordance with the syllabus approved by the
European Union of Medical Specialists and is expected to be
enforced before the end of 2014. The National Consultant in
Nuclear Medicine is responsible for the specialization program
in NM. The Medical Center of Postgraduate Training is the
administrative body which accepts the specialization programs,
supervises the training, organizes the examinations, and awards
the specialist title. Specialization in NM for physicians lasts for
five years. It consists of 36months of training in a native nuclear
medicine department, 12 months of internship in radiology, 3
months in cardiology, 3 months in endocrinology, 3 months in
oncology, and 3 months in two other departments of NM. If a
NM trainee is a specialist of a clinical discipline and/or is after a
long residency in NM departments, the specialization in NM
can be shortened to three years. During the training, there are
obligatory courses to be attended which include the elements of
anatomy imaging in USG, CT, and MR. Currently, there are
about 170 active NM specialists working for 38.5 million in-
habitants in Poland. For other professionals working in NM
departments, it is possible to get the title of a medical physics
specialist after completing 3.5 years of training (for those with a
master's in physics, technical physics or biomedical engineering)
or the title of a radiopharmacy specialist after completing 3 years
of training (for those with a master's in chemistry or biology). At
present, the specialization program in NM for nurses is being
developed by the Medical Centre of Postgraduate Education.
Continuing education and professional development are obliga-
tory for all physicians and governed by the Polish Medical
Chamber. The Polish Society of Nuclear Medicine (PTMN)
organizes regular postgraduate training for physicians working
in NM. Educational programs are comprehensive, covering both
diagnostics and current forms of radioisotope therapy. They are
aimed not only at physicians specialized/specializing in NM, but
also at other medical professionals employed in radionuclide
departments as well as physicians of other specialties.
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Historical notes
The first iodine treatment of thyroid disease was performed in
Poznań, Poland in 1952, and the first radioisotope center in
Poland was organized by Professor Maciej Gembicki at the
Department of Internal Diseases at Poznań University of
Medical Sciences as early as 1955–1956. In 1970, the Depart-
ment was appointed by IAEA to organize international train-
ing programs in radioimmunoassay methods. In the conduct
of these courses, 47 medical professionals from all over the
world were trained.
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In 1974, the first planar gamma camera was installed in
Poland; in 1982, the first SPECT; in 2003, the first PET/CT;
and in 2013, the first PET/MRI.
The Polish Society of Nuclear Medicine (PTMN, http://
www.ptmn.pl) was created in 1982 from the section of nuclear
medicine which had been established 10 years earlier at the
Polish Society of Radiology. The first congress of PTMN, held
every two years since then, took place in 1986. The Society
confederates around 450members. The Chairman of PTMN for
the last two terms of office has been Prof. Leszek Królicki.
In 1987, the official journal of PTMN, ‘Problemy
Medycyny Nuklearnej’ (‘Problems of Nuclear Medicine’),
was launched. The international ‘Nuclear Medicine Review,’
another biannual periodical of a scientific and educational
profile written in English, was established in Poland in
1998. The founders and first editors of the journal were Prof.
Piotr Lass and Prof. Julian Liniecki. Since 2011, both journals
have been merged and ‘Nuclear Medicine Review’ has be-
come the official journal of PTMN (http://www.nmr.
viamedica.pl). The periodical is indexed at Index
Copernicus, Scopus, EMBASE, Index Medicus/Medline and
is an official journal of the Polish, Hungarian, and Serbian
Societies of Nuclear Medicine.
The Polish Society of Nuclear Medicine is one of the
founding members of EANM, established in 1994.
Organizational workforce
At present, there are 63 departments (55 public and 8 non-
public) performing conventional imaging nuclear medicine in
Poland and there are 103 operating gamma cameras (16
SPECT/CT, 56 SPECT, 31 planar cameras). The majority of
applied radiopharmaceuticals are produced by a Polish radio-
isotope center (POLATOM).
After 10 years since the first PET center in Poland was
created [1], there are now 24 PET/CT (12 public and 12 non-
public) scanners and 1 PET/MR scanner (public) active, that
is, 1 scanner per 1.5 million inhabitants. At present, the
number of working cyclotrons dedicated to PET-
radiopharmaceutical synthesis equals 6. Radiopharmaceuti-
cals produced are generally used internally, as only one center
produces F-18-FDG commercially and the sites not
possessing a cyclotron mainly import F-18-FDG from Ger-
many or Austria.
In both public and non-public departments, on average,
about 80 % of studies are provided on the basis of concluded
contracts with the National Health Fund (NFZ).
About 170,000 classic nuclear medicine studies are con-
ducted yearly, and translate to 4.4 studies/1,000 inhabitants/
year and to around 1,650 scans/camera/year. In addition, more
than 20,000 therapies, designed mainly for non-cancer dis-
eases (85 %), are performed per year.
Around 38,000 PET studies are performed in total, and
these translate to about 1 study/1,000 inhabitants/year and
1,600 PET/CT scans/scanner/year.
The staff employed in nuclear medicine consists of over
1,000 persons: physicians (26 %), other personnel with univer-
sity degrees (18 %), nurses (21 %), technologists (15 %), and
other personnel (20 %). More than half of the doctors are
represented by nuclear medicine specialists (170). The number
of staff members involved in clinical PET/CT varies across the
centers; more technologists than physicists or medical doctors
are involved. There is a need to staff the PET/CT systems with
both a radiology-trained technologist and a nuclear medicine-
trained nurse. Systems with high throughput may require the
availability of a larger number of technologists to limit the total
radiation burden of each. There are more nuclear medicine
specialists involved than radiologists, as reflected in the low
frequency of contrast-enhanced PET/CTexaminations; howev-
er, all sites report the engagement of radiologists. Only three
sites employ dual-board-certified physicians.
The main responsibility of the National Consultant in Nu-
clear Medicine (Prof. Leszek Królicki, since 2000) and re-
gional consultants is to supervise professional development in
nuclear medicine and to control healthcare providers who
conduct postgraduate education and residency programs in
this field. They are also obliged to monitor healthcare acces-
sibility; to control medical equipment used by healthcare
providers; and to notify administration, healthcare providers,
regional departments of the National Health Fund, and the
Commissioner for Patients’ Rights of any abnormalities. The
consultants are often members of boards and committees
dealing with health policy implementation. They provide
opinions on workforce needs in the field as well as ensure
the implementation of current guidelines and procedures re-
garding diagnosis and treatment. Finally, they put forward
annual reports on the task status in the field of nuclear med-
icine. The National Consultant is additionally obliged to ad-
vise on the tasks performed by medical examination and
education centers as well as on the goals set by the National
Health Program and other health policy programs. The Na-
tional Consultant is also to project healthcare needs in the field
of nuclear medicine, and when asked by the Health Minister,
to give an opinion on the drafts of legal acts. Furthermore, the
National Consultant evaluates the applications concerning
healthcare provision abroad and advises the Health Minister
for the appointment of a new regional consultant.
Training resources and organization
Nuclear medicine specialization for physicians
In Poland, nuclear medicine has been an independent specialty
since 1988. At the end of 2013, the syllabus for postgraduate
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specialization in nuclear medicine has been modified to be in
close accordance with the syllabus approved by the European
Union of Medical Specialists (UEMS) [2] and is expected to
be enforced before the end of 2014. The National Consultant
in Nuclear Medicine is responsible for the specialization pro-
gram, and the Medical Center of Postgraduate Training is the
administrative bodywhich accepts the specialization program,
supervises the training, acknowledges departments where
training can be done, organizes the examinations (twice a
year), and finally, awards the specialist title.
Specialization in nuclear medicine lasts for five years. It
consists of 36 months of training in a native nuclear medicine
department, 12 months of internship in radiology,
three months in cardiology, three months in endocrinology,
three months in oncology, and three months in two other
departments of nuclear medicine (with other technologies
and/or other types of medical examinations performed). If a
nuclear medicine trainee is a specialist of a clinical discipline
and/or is after a long residency in Polish or foreign nuclear
medicine departments, the specialization in nuclear medicine
can be shortened to three years. During the training, there are
obligatory courses to be attended. The basic courses include
introduction to nuclear medicine (30 h) as well as radiation
protection, emergency medicine, public health, and medical
law. The advanced courses cover the radionuclide studies of
the cardiovascular system; PET, SPECT, and hybrid imaging
in oncology; diagnostics of the nervous system; radioisotope
therapy; and the elements of anatomy imaging in USG, CT,
and MR. After completing the training, there is a centrally
organized specialization examination, which consists of a
written part (test) and a practical part.
Currently, there are about 170 active nuclear medicine
specialists working for 38.5 million inhabitants in Poland.
Specializations for other professionals working in nuclear
medicine departments
For those with a master's in physics, technical physics or
biomedical engineering, it is possible to get the title of a
medical physics specialist after completing 3.5 years of train-
ing and after passing the final national examination. The train-
ing includes 520 h of course activities (lectures, presentations,
exercises) and 22 weeks of practical training. Courses on diag-
nostic imaging cover 60 h, and on nuclear medicine, 50 h (35 for
diagnostics and 15 for therapy). Practical training contains diag-
nostic imaging (4 weeks) and nuclear medicine diagnostics and
therapy (4 weeks); training in nuclear medicine must be carried
out in at least two places, and at least one of those places must be
equipped with a PETscanner. The other courses cover the basics
of human anatomy and physiology, the basics of radiobiology,
elements of radiation physics, methods of radiation detection and
dosimetry, radiation protection, teleradiotherapy, brachytherapy,
non-ionising radiation therapy, bioelectricity and biomagnetism
in diagnostics, statistics, elements of medical informatics, and
legal and organizational issues. Commencing in 2016, only
medical physics specialists will be allowed to perform the ad-
vanced nuclear medicine QC procedures. Currently, in nuclear
medicine, there are 17 medical physicists with specialization
completed or who are enrolled in the specialization program.
Similarly, for those with a master's in chemistry or biology,
commencing in 2014, getting a radiopharmacy specialist title
becomes possible after completing three years of training and
after passing the final national examination. The training in-
cludes 167 h of courses for theoretical training and 85 h of
practical training. The main goal is a comprehensive education
in organizing, performing, and supervising the preparation of
radiopharmaceuticals satisfying current requirements. The main
courses cover work in aseptic environments, radiation protection
during labeling and portioning, radiopharmaceutical preparation
and quality control in healthcare units, preparation of radiophar-
maceuticals for PET and non-authorised radiopharmaceuticals,
and clinical applications of radiopharmaceuticals. Practical train-
ing corresponds to all the topics. The other courses cover the
basis of pharmacy and legal issues, the basis of radiopharmacy,
and the directions of development for radiopharmacy.
Nuclear medicine specialization for nurses
There is a group of over 350 active electroradiology technol-
ogists (approx. 150) and nurses (approx. 200) working in
nuclear medicine departments. For 15 years, the Polish Soci-
ety of Nuclear Medicine has been organizing 1-day courses at
least twice a year for the continuing education of these groups.
At present, the specialization program in nuclear medicine
for nurses is being developed by the Medical Centre of Post-
graduate Education. The training will include 32 h of lectures
and 35 h of practical training. The topics will cover radiation
protection with elements of radiopharmacology and imaging
techniques, medical care of oncology patients during radionu-
clide diagnostics and therapy, medical care of endocrinology
patients during radionuclide diagnostics and therapy, medical
care of cardiology patients during radionuclide diagnostics,
and medical care during other scintigraphic procedures.
Continuing education and professional development
Continuing education and professional development are
obligatory for all physicians and governed by the Polish
Medical Chamber. The general system of credit points in
Poland was introduced many years ago; the points are granted
by the PolishMedical Chamber and a 4-year settlement period
is applied. The responsibility for organizing the upgrade of
knowledge trainingmeetings and courses is within the PTMN.
The number of credit points achieved is dependent on the
program and duration of the course.
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The PTMN organizes regular postgraduate training (two to
three times a year) for physicians working in nuclear medicine.
Additionally, symposia/conferences/workshops/courses are or-
ganized each year in collaboration with other scientific
societies/organizations like the National Center of Radiation
Protection, Polish Society of Endocrinology, Polish Society of
Cardiology, Polish Society of Neurology, Polish Society of
Oncology, and Polish Society of Radiology. The goal is to
update the knowledge of nuclear medicine specialists on radio-
nuclide diagnostics as well as on other diagnostic techniques
and clinical applications. Simultaneously, the knowledge about
the possibilities of nuclear medicine diagnostic and therapeutic
techniques is passed to the doctors of different specializations.
One nuclear medicine department in Poland owns the
UEMS/EBNM accreditation for the years 2010–2014. The
Polish Ministry of Health, in collaboration with PTMN, has
been preparing the program of clinical audits for voluntary
nuclear departments. The basic stage of the program, writing
all the model procedures, was completed by nuclear medicine
experts at the end of 2013.
International recognition
Three persons have been awarded with the European special-
ization certificate in radiopharmacy by the Radiopharmacy
Committee of EANM.
Numerous members of the Polish nuclear medicine com-
munity have contributed to the progress of the specialty via
their activities for EANM and UEMS/EBNM:
– Prof. Maciej Gembicki was the Vice-President of the
EANM from 1983 to 1986.
– Prof. Gembicki (1975–1984) and Prof. Anna Tarkowska
(1988–1993) were members of the Eur J Nucl Med
Editorial Board.
– Some specialists have been members of different com-
mittees: ● Renata Mikołajczak (Member of the EANM
Radiopharmacy Committee 2000–2008, and organizer of
the 12th European Symposium on Radiopharmacy and
Radiopharmaceuticals, held in Gdańsk, Poland, 2004); ●
Anna Płachcińska (Member of the EANMTask Group on
Quality Assurance and Standardisation 2000–2001, and
EANM Physics Committee 2006–2012); ● Jolanta
Kunikowska (Member of the EANMOncology Commit-
tee, at present); ●Daria Handkiewicz-Junak (Secretary of
the EANM Radionuclide Therapy Committee, at
present).
– Bożena Birkenfeld and Mirosław Dziuk currently hold
the position of National Delegates to the UEMS/EBNM;
Jolanta Kunikowska and RafałCzepczyński are delegates
to EANM; and Janusz Kapuściński is a member of
EANM Radiopharmacy Committee.
Historically, the first European School of NuclearMedicine
had been started by the Polish Society of Nuclear Medicine
(1st ESNM Seminar, Warsaw 1995) and three seminars were
organized in Poland since then (28th - Warsaw 2004, 36th -
Szczecin 2007, and 45th -Warsaw 2010). The local organizers
were Dr. Krzysztof Toth, Prof. Leszek Królicki (Warsaw), and
Prof. Bożena Birkenfeld (Szczecin).
Beyond the activities for EANM and UEMS/EBNM, Pol-
ish professionals have worked for important international
organizations connected with nuclear medicine:
– Prof. Julian Liniecki was the expert of the United Nations
Scientific Committee on the Effects of Atomic Radiation
(UNSCEAR), and from 1964 to 1966 as well as from
1978 to 1986 was the Scientific Secretary of UNSCEAR;
he was also a member (now emeritus) from 1969 to
present of the International Committee on Radiological
Protection (ICRP) Task Group 36 dealing with radiophar-
maceutical dosimetry.
– Prof. Maciej Gembicki, in the 1980s, was an expert and a
member of the Secretariat of the IAEA in Vienna as well
as a WHO expert in charge of providing assistance in
organizing centers of nuclear medicine and of promoting
research and training in nuclear medicine in many coun-
tries of the world.
– Prof. Zbigniew Szybiński, from 1982 to 1994, was an
expert of IAEA for the action “Atom for Peace” and
organizer of the first nuclear medicine departments in the
Sierra Leone capitol and in the University of Malaysia.
– Prof. Eugeniusz Dziuk, from 1990 to 1991, was an IAEA
expert with missions to Zimbabwe, Mongolia, Vietnam,
and Ethiopia, and the organizer of IAEA Fellowship
training for six doctors from Middle Asia at the Depart-
ment of Nuclear Medicine, Military Institute ofMedicine,
Warsaw.
– Prof. Barbara Jarząb, since 2001, connects the nuclear
medicine with European endocrinology and oncology in
the field of thyroid diseases; she is also a member of the
European Thyroid Association (ETA), member of the
Executive Committee from 2006 to 2009, and was Sec-
retary of ETA-CNR (Cancer Research Network) from
2009 to 2013; and organizer of five international ETA
meetings (2009 - Portugal, 2010 - France, 2011 - Poland,
2012 - Italy, and 2013 - the Netherlands).
– Prof. Bożena Birkenfeld, from 2002 to 2005, was an
IAEA expert with missions to Tajikistan, Georgia, Ka-
zakhstan, Uzbekistan and was also the organizer of IAEA
Fellowship training for five doctors from Middle Asia at
the Department of Nuclear Medicine, Pomeranian Med-
ical University in Szczecin. She was also a local organizer
of the International Satellite Symposium “Radioisotope
Imaging of Infection and Inflammation” (Szczecin-
Strzekęcin, 1998) at the 7th Congress of WFNM&B in
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Berlin and the IAEA Regional Training Course
“Scintimammography, lymphoscintigraphy and sentinel
lymph node detection” (Szczecin, 2002).
– Prof. Alicja Hubalewska-Dydejczyk, from 2008 to 2010,
was the President of the International Research Group in
Immuno-Scintigraphy and Therapy (IRIST) and the Pres-
ident of the 19th IRIST Congress held in Kraków, Poland,
2008; she is an Executive Board Member at present.
– Dr. Renata Mikołajczak is an IAEA expert in the area of
radiopharmaceuticals.
Final comments
Educational programs in nuclear medicine in Poland are very
comprehensive, covering both diagnostics and current forms
of radioisotope therapy. They are aimed not only at physicians
specializing in nuclear medicine, but also at other medical
professionals employed in radionuclide departments as well as
physicians of other specialties.
Postgraduate education and professional development re-
quire interpretation of hybrid images and therefore, require
skills in evaluating CT and MRI scans. We are working to
allow specialists in nuclear medicine to authorize the results of
structural examinations.
Our specialists are thoroughly trained in personalized
medicine. We find this approach very promising as nuclear
medicine offers a wide variety of diagnostic and therapeu-
tic tools that can be applied to patients on an individual
basis.
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